The Food and Drug Administration (FDA) posted an alert this month warning that patients who use continuous glucose monitors (CGMs), insulin pumps, automated insulin dosing systems, and other diabetes devices are at risk of not receiving or not hearing audible alerts from their smartphones regarding their devices. A missed alert could possibly lead to severe hypoglycemia, severe hyperglycemia, diabetic ketoacidosis, and death, the agency says. Because apps for diabetes CGMs and other devices allow users …
Read More